Buenos Aires - Delayed Quote ARS

Merck & Co., Inc. (MRK.BA)

18,900.00

+250.00

+(1.34%)

As of 3:21:31 PM GMT-3. Market Open.

Merck warns of big tariff hit, Hasbro soars, Comcast sinks

Julie Hyman provides an overview of the top stories of the trading day in just 60 seconds on Yahoo Finance's Market Minute. Merck & Company (MRK) warns investors that it expects a $200 million hit from tariffs. Hasbro (HAS) stock is soaring after reporting a first quarter earnings beat. Comcast (CMCSA) stock sinks after reporting a larger-than-expected loss in broadband customers. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 1 hour ago

MRK

HAS

CMCSA
Why vaccine makers aren't worried about Trump administration cuts

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Yahoo Finance 23 hours ago

MRNA

MRK

SNY
Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

Merck (NYSE:MRK) experienced a 2.98% share price increase over the past week, during which several key developments occurred. The company reaffirmed its 2025 financial guidance, despite a slight decline in Q1 sales and ongoing patent litigation with Halozyme Therapeutics. Meanwhile, broader market movements, boosted by a tech-driven rally and anticipation of tariff news, provided a favorable backdrop. The market, seeing an overall 2.3% increase, suggested positive sentiment, possibly...

Simply Wall St. 37 minutes ago

MRK
Merck Cuts 2025 Outlook on Tariffs, Charges

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.

The Wall Street Journal 2 hours ago

MRK
Stocks to Watch Thursday: P&G, IBM, Merck, ServiceNow

↘️ IBM (IBM): The tech company warned that macroeconomic uncertainty was prompting businesses to rethink spending. Shares slid more than 7%, despite IBM posting better-than-expected quarterly results.

The Wall Street Journal 4 hours ago

MRK

NOW

TSLA
Merck takes $200M tariff hit, trimming its gross profits

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.

BioPharma Dive 7 hours ago

MRK
Merck’s (NYSE:MRK) Q1 Sales Beat Estimates

Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.

StockStory 7 hours ago

MRK
Merck: Q1 Earnings Snapshot

RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $5.08 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share.

Associated Press Finance 8 hours ago

MRK
Merck Stock Takes A Hit As Gardasil 'Woes' Continue In China, Japan

Merck stock slumped Thursday after the company reported another quarter of light sales for its HPV vaccine.

Investor's Business Daily 8 hours ago

MRK
Merck Announces First-Quarter 2025 Financial Results

RAHWAY, N.J., April 24, 2025--Merck Announces First-Quarter 2025 Financial Results

Business Wire 8 hours ago

MRK
BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investor's Business Daily 22 hours ago

BNTX

MRK

SMMT
Is Merck & Co., Inc. (MRK) the Best Stock To Buy According to Marjorie Taylor Greene?

We recently published a list of 20 Best Stock To Buy According to Marjorie Taylor Greene. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks to buy according to Marjorie Taylor Greene. Marjorie Taylor Greene is one of the most active members of […]

Insider Monkey yesterday

MRK
Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

Global pharmaceutical company Merck (NYSE:MRK) will be reporting results tomorrow before market hours. Here’s what to expect.

StockStory yesterday

MRK
Merck & Co., Inc. (MRK): Among Prem Watsa’s Stock Picks With Highest Potential

We recently compiled a list of Billionaire Prem Watsa’s 10 Stock Picks With Highest Potential. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Prem Watsa’s other stock picks. Momentum and technology stocks have dominated the markets over the past decade. They have been the catalyst […]

Insider Monkey yesterday

MRK

FAXRF
Merck Q1 Earnings Coming Up: Should You Buy the Stock Now?

When Merck reports first-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.

Zacks 2 days ago

MRK
Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with pemetrexed and platinum chemotherapy, for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma (MPM). The approval is based on data from the pivotal Phase 3 IND.227/KEYNOTE-483 trial, which demonstrated a statistically significant improvement

CNW Group 2 days ago

MRK
Merck & Co., Inc. (MRK): Among Value Stocks in Ken Fisher’s Portfolio

We recently published a list of 10 Value Stocks in Ken Fisher’s Portfolio. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail; that’s the sentiment echoed by billionaire investor Ken Fisher as their […]

Insider Monkey 5 days ago

MRK
Why Merck, Black Hills, And Virtus Investment Partners Are Winners For Passive Income

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Merck, Black Hills, and Virtus Investment Partners have rewarded shareholders for years and recently announced dividend increases. These companies currently offer dividend yields of around 4-6%. Merck Merck (NYSE:MRK) is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, c

Benzinga 5 days ago

BKH

VRTS

MRK
Is Merck & Co., Inc. (MRK) the Best Large-Cap Value Stock to Buy as the Recession Hits?

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that equities around the world […]

Insider Monkey 6 days ago

MRK
Stocks to watch this week: Tesla, Alphabet, Intel, Boeing and Unilever

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 6 days ago

DELHY

DLVHF

IHCPF

Performance Overview

Return	MRK.BA	S&P 500 (^GSPC)
YTD	-19.32%	-6.82%
1-Year	-29.79%	+8.06%
3-Year	+435.34%	+28.30%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Merck & Co., Inc. (MRK.BA)

Merck warns of big tariff hit, Hasbro soars, Comcast sinks

Why vaccine makers aren't worried about Trump administration cuts

Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

Merck Cuts 2025 Outlook on Tariffs, Charges

Stocks to Watch Thursday: P&G, IBM, Merck, ServiceNow

Merck takes $200M tariff hit, trimming its gross profits

Merck’s (NYSE:MRK) Q1 Sales Beat Estimates

Merck: Q1 Earnings Snapshot

Merck Stock Takes A Hit As Gardasil 'Woes' Continue In China, Japan

Merck Announces First-Quarter 2025 Financial Results

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

Is Merck & Co., Inc. (MRK) the Best Stock To Buy According to Marjorie Taylor Greene?

Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

Merck & Co., Inc. (MRK): Among Prem Watsa’s Stock Picks With Highest Potential

Merck Q1 Earnings Coming Up: Should You Buy the Stock Now?

Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)

Merck & Co., Inc. (MRK): Among Value Stocks in Ken Fisher’s Portfolio

Why Merck, Black Hills, And Virtus Investment Partners Are Winners For Passive Income

Is Merck & Co., Inc. (MRK) the Best Large-Cap Value Stock to Buy as the Recession Hits?

Stocks to watch this week: Tesla, Alphabet, Intel, Boeing and Unilever

Performance Overview